These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9636860)

  • 1. Why have group A streptococci remained susceptible to penicillin? Report on a symposium.
    Horn DL; Zabriskie JB; Austrian R; Cleary PP; Ferretti JJ; Fischetti VA; Gotschlich E; Kaplan EL; McCarty M; Opal SM; Roberts RB; Tomasz A; Wachtfogel Y
    Clin Infect Dis; 1998 Jun; 26(6):1341-5. PubMed ID: 9636860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance of normal oropharyngeal flora in the development of streptococcal pharyngitis and outcome of penicillin therapy].
    Mihajlović-Ukropina M; Roncević N
    Med Pregl; 1998; 51(5-6):275-8. PubMed ID: 9720358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Streptococcal tonsillitis: failure of penicillin therapy].
    Schønheyder HC
    Ugeskr Laeger; 1994 Mar; 156(13):1931-4. PubMed ID: 8009683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in sensitivity to penicillin and an increase in virulence in beta-hemolytic streptococci followed by changes in the clinical picture of streptococcal syndrome].
    Berger-Jekić O; Ranin L; Vuković-Opavski N
    Srp Arh Celok Lek; 1993; 121(3-7):87-8. PubMed ID: 7716645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why do we fail with penicillin in the treatment of group A streptococcus infections?
    Sela S; Barzilai A
    Ann Med; 1999 Oct; 31(5):303-7. PubMed ID: 10574501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of the continuing susceptibility of group A streptococcal strains to penicillin during eight decades.
    Macris MH; Hartman N; Murray B; Klein RF; Roberts RB; Kaplan EL; Horn D; Zabriskie JB
    Pediatr Infect Dis J; 1998 May; 17(5):377-81. PubMed ID: 9613649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vivo protection of group A beta-haemolytic streptococci from penicillin by beta-lactamase-producing Bacteroides species.
    Brook I; Pazzaglia G; Coolbaugh JC; Walker RI
    J Antimicrob Chemother; 1983 Dec; 12(6):599-606. PubMed ID: 6363381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Penicillin failure and copathogenicity in streptococcal pharyngotonsillitis.
    Brook I
    J Fam Pract; 1994 Feb; 38(2):175-9. PubMed ID: 8308510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of penicillin versus cefdinir in eradication of group A streptococci and tonsillar flora.
    Brook I; Foote PA
    Antimicrob Agents Chemother; 2005 Nov; 49(11):4787-8. PubMed ID: 16251332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance to erythromycin and rising penicillin MIC in Streptococcus pyogenes in India.
    Capoor MR; Nair D; Deb M; Batra K; Aggarwal P
    Jpn J Infect Dis; 2006 Oct; 59(5):334-6. PubMed ID: 17060703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of penicillin in Streptococcus pyogenes pharyngeal infection.
    Gillespie SH
    Lancet; 1998 Dec 19-26; 352(9145):1954-6. PubMed ID: 9872242
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of beta-hemolytic streptococcal pharyngitis with cefaclor or penicillin. Efficacy and interaction with beta-lactamase-producing organisms in the pharynx.
    Reed BD; Huck W; Zazove P
    J Fam Pract; 1991 Feb; 32(2):138-44. PubMed ID: 1990041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The minimum inhibitory concentrations of penicillin against various sterotypes of streptococci--its clinical implications.
    Rolston DK; Brahmadathan KN; Koshi G; Cherian G
    J Assoc Physicians India; 1979 Feb; 27(2):127-8. PubMed ID: 389922
    [No Abstract]   [Full Text] [Related]  

  • 14. Have group A streptococci with reduced penicillin susceptibility emerged?
    Suzuki T; Kimura K; Suzuki H; Banno H; Jin W; Wachino J; Yamada K; Arakawa Y
    J Antimicrob Chemother; 2015 Apr; 70(4):1258-9. PubMed ID: 25473026
    [No Abstract]   [Full Text] [Related]  

  • 15. [Is penicillin still the drug of choice in the treatment of diseases caused by beta-hemolytic streptococci?].
    Ranin L; Vucković-Opavski N; Berger-Jekić O
    Srp Arh Celok Lek; 1993; 121(8-12):133-6. PubMed ID: 7725154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controversies in the treatment of streptococcal pharyngitis.
    Pichichero ME
    Am Fam Physician; 1990 Dec; 42(6):1567-76. PubMed ID: 2244548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Streptococcus pyogenes: penicillin and erythromycin susceptibility in the cities of Neuquen and Cipolletti].
    Soriano SV; Brasili S; Saiz M; Carranza C; Vidal P; Calderón J; Lopardo HA
    Medicina (B Aires); 2000; 60(4):487-90. PubMed ID: 11188957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Streptococci, penicillin and organism resistance. Failure of penicillin treatment of streptococcal infections of the upper respiratory tract].
    Milić V; Guberinić M; Marjanović A; Radojcić V; Bokan O
    Srp Arh Celok Lek; 1982 Nov; 110(11):1349-60. PubMed ID: 7185187
    [No Abstract]   [Full Text] [Related]  

  • 19. Systematic review of factors contributing to penicillin treatment failure in Streptococcus pyogenes pharyngitis.
    Pichichero ME; Casey JR
    Otolaryngol Head Neck Surg; 2007 Dec; 137(6):851-857. PubMed ID: 18036409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of macrolide-resistance and comparative activity of telithromycin in streptococci in Austria, 1996-2002.
    Buxbaum A; Forsthuber S; Sauermann R; Gattringer R; Graninger W; Georgopoulos A;
    Int J Antimicrob Agents; 2004 Oct; 24(4):397-400. PubMed ID: 15380268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.